Selective JAK1 Inhibitors for Treatment of Atopic Dermatitis Review the role of the JAK/STAT pathway in atopic dermatitis, and the pharmacology of the JAK1 inhibitors upadacitinib and abrocitinib, ...

Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...

A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Strategies to bring clinical trials closer to patients gained ...

By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...

Clinicians routinely provide harm-reduction measures and anticipatory guidance for a range of complex health issues (e.g., substance use and vaccination), capitalizing on available evidence, their ...

NIH grant terminations disrupted 3.5% of active clinical trials, affecting over 74,000 participants and resulting in a $1.81 billion funding loss. The National Institute of Mental Health and the ...

Celltrion announced on April 2 that a paper detailing the results of a post-hoc analysis from the global Phase 3 clinical trial of 'Zympendra' (the ...

Journal clubs have long been a cornerstone of medical education, serving as platforms for critical appraisal and discussion of contemporary research. Traditionally led by faculty, these forums ...

WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA ® (finerenone) significantly reduced urine ...

Renowned clinical researcher and CEO of the Baim Institute Dr. Gibson joins DrKumo to drive innovation in pharma ...